SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $2.97K invested in Sonnet BioTherapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$255K
2
-$223K
3
-$31K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$15.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$13.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.53K
2
$435
3
$3
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–